Kishihara Y - Search Results

1

Large dose natural interferon alpha therapy for patients with chronic hepatitis C.

Ohmiya M, Hayashi J, Furusyo N, Ueno K, Kishihara Y, Nabeshima S, Kashiwagi S. Ohmiya M, et al. Among authors: kishihara y. Fukuoka Igaku Zasshi. 1997 Dec;88(12):380-8. Fukuoka Igaku Zasshi. 1997. PMID: 9465478 Clinical Trial.

2

Serum levels of soluble interleukin-2 receptors and effects of interferon-alpha for patients with chronic hepatitis C virus.

Hayashi J, Kishihara Y, Yamaji K, Yoshimura E, Ohmiya M, Tani Y, Ikematsu H, Kashiwagi S. Hayashi J, et al. Among authors: kishihara y. Dig Dis Sci. 1995 Aug;40(8):1837-41. doi: 10.1007/BF02212710. Dig Dis Sci. 1995. PMID: 7648988

3

Improved detection of antibodies to hepatitis C virus by the second-generation assay in patients with chronic non-A, non-B liver disease.

Hayashi J, Nakashima K, Kishihara Y, Ohmiya M, Yoshimura E, Hirata M, Kashiwagi S. Hayashi J, et al. Among authors: kishihara y. J Infect. 1993 May;26(3):287-94. doi: 10.1016/0163-4453(93)95443-m. J Infect. 1993. PMID: 7685043

4

A preliminary study of retreatment of chronic hepatitis C with interferon.

Kishihara Y, Hayashi J, Ohmiya M, Nakashima K, Ikematsu H, Kashiwagi S. Kishihara Y, et al. Fukuoka Igaku Zasshi. 1995 Apr;86(4):113-20. Fukuoka Igaku Zasshi. 1995. PMID: 7782023 Clinical Trial.

5

A statistical analysis of predictive factors of response to human lymphoblastoid interferon in patients with chronic hepatitis C.

Hayashi J, Ohmiya M, Kishihara Y, Tani Y, Kinukawa N, Ikematsu H, Kashiwagi S. Hayashi J, et al. Among authors: kishihara y. Am J Gastroenterol. 1994 Dec;89(12):2151-6. Am J Gastroenterol. 1994. PMID: 7977232 Clinical Trial.

6

Effectiveness of relative low-dose interferon treatment for patients with chronic hepatitis C.

Hayashi J, Kishihara Y, Tani Y, Yamaji K, Nakashima K, Ikematsu H, Kashiwagi S. Hayashi J, et al. Among authors: kishihara y. Fukuoka Igaku Zasshi. 1994 Jul;85(7):211-8. Fukuoka Igaku Zasshi. 1994. PMID: 8070751

7

Evaluation of quantitative assay for antibody to hepatitis C virus core in patients treated with interferon.

Yoshimura E, Hayashi J, Kishihara Y, Yamaji K, Kinukawa N, Kashiwagi S. Yoshimura E, et al. Among authors: kishihara y. Dig Dis Sci. 1996 Jan;41(1):155-60. doi: 10.1007/BF02208598. Dig Dis Sci. 1996. PMID: 8565749

8

IL-1 beta and TNF-alpha produced by peripheral blood mononuclear cells before and during interferon therapy in patients with chronic hepatitis C.

Kishihara Y, Hayashi J, Yoshimura E, Yamaji K, Nakashima K, Kashiwagi S. Kishihara Y, et al. Dig Dis Sci. 1996 Feb;41(2):315-21. doi: 10.1007/BF02093821. Dig Dis Sci. 1996. PMID: 8601375

9

Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection.

Hayashi J, Kishihara Y, Yamaji K, Furusyo N, Yamamoto T, Pae Y, Etoh Y, Ikematsu H, Kashiwagi S. Hayashi J, et al. Among authors: kishihara y. Hepatology. 1997 Mar;25(3):697-701. doi: 10.1002/hep.510250334. Hepatology. 1997. PMID: 9049221

10

No significant changes in levels of hepatitis C virus (HCV) RNA by competitive polymerase chain reaction in blood samples from patients with chronic HCV infection.

Yoshimura E, Hayashi J, Ueno K, Kishihara Y, Yamaji K, Etoh Y, Kashiwagi S. Yoshimura E, et al. Among authors: kishihara y. Dig Dis Sci. 1997 Apr;42(4):772-7. doi: 10.1023/a:1018860029661. Dig Dis Sci. 1997. PMID: 9125647

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters